Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer – Medical Xpress
Medical Xpress |
Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer
Medical Xpress Though chemotherapy and immunotherapy have become standard options for the treatment of metastatic bladder cancer, it was previously unknown whether these therapies could be given together and whether chemotherapy’s side effect of weakening the immune … |
Medical Xpress |
Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer
Medical Xpress Though chemotherapy and immunotherapy have become standard options for the treatment of metastatic bladder cancer, it was previously unknown whether these therapies could be given together and whether chemotherapy’s side effect of weakening the immune … |
Endpoints News |
French CAR–T Developer Raises $164M in Follow-on Offering Despite a Challenging Road
Labiotech.eu (blog) Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed results in the technology’s development up until now. Cellectis, based in Paris, has closed a follow-on offering … Flush with a $164M raise, Cellectis ups its bet on CAR–T and gene editing programsEndpoints News |
|
Stem Cell Transplant Dr. Eugen Michael Molnar has CA Medical License Revoked
OC Weekly Molnar later moved to Los Angeles, where he was in private practice for head, neck, plastic and reconstructive surgery. His father’s death from complications from diabetes in 1976 plunged Molnar into the study of incurable and non-treatable diseases … |
|
Metalytics Debuts World’s Most Advanced Metabolic Flux Analysis Offering, CoreMFA®
PR Newswire (press release) The ultimate goal of metabolic engineering–the practice of optimizing the conversion of these raw materials into the necessary molecules, is high-yield production of valuable substances on an industrial scale in a cost-effective manner. With CoreMFA … |
Genetic Literacy Project |
Podcast: Geneticist George Church on the future of synthetic biology
Genetic Literacy Project George Church’s Harvard lab is one of the most celebrated fonts of innovation in the world of life sciences. George’s earliest work on the Human Genome Project arguably pre-dated the actual start of that project. … Much of George’s most recent and … Growth Opportunities in the Synthetic Biology Market, Forecast to 2024Pharmaceuticals News |